לקסיבה

Страна: Ізраїль

мова: іврит

Джерело: Ministry of Health

Активний інгредієнт:

FOSAMPRENAVIR AS FOSAMPRENAVIR CALCIUM 700 MG

Доступна з:

GLAXO SMITH KLINE (ISRAEL) LTD

Код атс:

J05AE07

Фармацевтична форма:

TABLETS

Адміністрація маршрут:

PER OS

Виробник:

GLAXO WELLCOME SA, SPAIN

Терапевтична група:

FOSAMPRENAVIR

Терапевтичні свідчення:

Lexiva is indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV) infection in adults. The following points should be considered when initiating therapy with Lexiva/ritonavir in protease inhibitor - experienced patients: - The protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that Lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - Once - daily administration of Lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Дата Авторизація:

2012-01-01